Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $6.05 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.